|
| 37141854 | Noncompetitive immunoassay optimized for pharmacokinetic assessments of biologically active efruxifermin. | | 2023 |
| 34773249 | Efruxifermin, a long-acting Fc-fusion FGF21 analogue, reduces body weight gain but does not increase sympathetic tone or urine volume in Sprague Dawley rats. | British Journal of Pharmacology | 2022 |
| 36644237 | A randomized, double-blind, placebo-controlled phase IIa trial of efruxifermin for patients with compensated NASH cirrhosis. | JHEP Rep | 2022 |
| 34239138 | Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial. | Nat Med | 2021 |
| 33176135 | Muscle-Liver Trafficking of BCAA-Derived Nitrogen Underlies Obesity-Related Glycine Depletion. | Cell Rep | 2020 |
| 31959001 | Variations in rest-activity rhythm are associated with clinically measured disease severity in Parkinson's disease. | Chronobiology International | 2020 |
| 31948295 | Fibroblast growth factor (FGF)-21 based therapies: A magic bullet for nonalcoholic fatty liver disease (NAFLD)? | Expert Opinion on Investigational Drugs | 2020 |
| 33381084 | FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases. | Frontiers in Endocrinology | 2020 |
| 33205064 | AKR-001, an Fc-FGF21 Analog, Showed Sustained Pharmacodynamic Effects on Insulin Sensitivity and Lipid Metabolism in Type 2 Diabetes Patients. | Cell Reports Medicine | 2020 |
| 31092695 | Human sebum requires de novo lipogenesis, which is increased in acne vulgaris and suppressed by acetyl-CoA carboxylase inhibition. | Sci Transl Med | 2019 |
| 29664898 | Correction: Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain. | PLoS Biol | 2018 |
| 28289077 | Selective Activation of AMPK 1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy. | Journal of Pharmacology and Experimental Therapeutics | 2017 |
| 28573777 | Once-weekly administration of a long-acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non-human primates. | Diabetes, Obesity and Metabolism | 2017 |
| 28323820 | Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain. | PLoS Biol | 2017 |
| 27746128 | A Small-Molecule Anti-secretagogue of PCSK9 Targets the 80S Ribosome to Inhibit PCSK9 Protein Translation. | Cell Chemical Biology | 2016 |
| 27113485 | Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy. | Journal of the American Society of Nephrology : JASN | 2016 |
| 27391855 | Discovery of a Selective Covalent Inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in Metabolism. | ACS Chemical Biology | 2016 |
| 26748706 | The Acetyl Group Buffering Action of Carnitine Acetyltransferase Offsets Macronutrient-Induced Lysine Acetylation of Mitochondrial Proteins. | Cell Rep | 2016 |
| 27059951 | Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus. | Diabetes, Obesity and Metabolism | 2016 |
| 26959184 | A Long-Acting FGF21 Molecule, PF-05231023, Decreases Body Weight and Improves Lipid Profile in Non-human Primates and Type 2 Diabetic Subjects. | | 2016 |
| 26734723 | Optimization of a Dicarboxylic Series for in Vivo Inhibition of Citrate Transport by the Solute Carrier 13 (SLC13) Family. | Journal of Medicinal Chemistry | 2016 |
| 27408778 | Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export. | Mol Metab | 2016 |
| 26620127 | Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5). | Scientific Reports | 2015 |
| 26389676 | Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells. | J Clin Invest | 2015 |
| 26254576 | Impact of combined resistance and aerobic exercise training on branched-chain amino acid turnover, glycine metabolism and insulin sensitivity in overweight humans. | Diabetologia | 2015 |
| 26153793 | FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance. | Scientific Reports | 2015 |
| 24584071 | Loss-of-function mutations in SLC30A8 protect against type 2 diabetes. | Nat Genet | 2014 |
| 24858947 | The hepatoselective glucokinase activator PF-04991532 ameliorates hyperglycemia without causing hepatic steatosis in diabetic rats. | PLoS ONE | 2014 |
| 24097065 | Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes. | Nat Genet | 2013 |
| 22196621 | Discovery of (S)-6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid as a hepatoselective glucokinase activator clinical candidate for treating type 2 diabetes mellitus. | Journal of Medicinal Chemistry | 2012 |
| 9300538 | Duration of protective immunity against ovine haemonchosis following vaccination with the nematode gut membrane antigen H11. | Research in Veterinary Science | 1997 |
| 8945548 | Induction of protective immunity in cattle against infection with Fasciola hepatica by vaccination with cathepsin L proteinases and with hemoglobin. | Infection and Immunity | 1996 |
| 7558570 | Vaccination of sheep against haemonchosis with H11, a gut membrane-derived protective antigen from the adult parasite: prevention of the periparturient rise and colostral transfer of protective immunity. | International Journal for Parasitology | 1995 |
| 7635627 | Protection against multiply drug-resistant and geographically distant strains of Haemonchus contortus by vaccination with H11, a gut membrane-derived protective antigen. | International Journal for Parasitology | 1995 |
| 7831742 | Influence of the beta-agonist salbutamol on claw horn lesions and walking soundness in finishing pigs. | Veterinary Record | 1994 |
| 22061653 | Eating quality of meat from pigs given the beta-adrenergic agonist salbutamol. | Meat Science | 1991 |
| 2262419 | Interactions between the beta-adrenergic agonist salbutamol and genotype on meat quality in pigs. | Journal of Animal Science | 1990 |
| 2303392 | The effects of the beta-adrenergic agonist salbutamol on meat quality in pigs. | Journal of Animal Science | 1990 |
| 2277183 | Studies on the growth of the fetal guinea pig. The effects of nutritional manipulation on prenatal growth and plasma somatomedin activity and insulin-like growth factor concentrations. | | 1990 |
| 2746724 | The effects of salbutamol on blood pressure and heart rate in Large White and Pietrain-cross breeds of pig. | Journal of Veterinary Pharmacology and Therapeutics | 1989 |
| 3885272 | Metabolism during fetal life: a functional assessment of metabolic development. | Physiological Reviews | 1985 |
| 6526985 | Studies on the growth of the fetal guinea pig. The effects of ligation of the uterine artery on organ growth and development. | | 1984 |
| 6300215 | Regulation of glycolytic flux in the heart of the fetal guinea pig. | | 1983 |
| 7202024 | Delayed development of gluconeogenic capacity and the appearance of hypoglycaemia in the newborn guinea-pig after intra-uterine growth restriction. | | 1982 |
| 6211993 | Ultrastructural and enzymatic development of fetal guinea pig heart. | American Journal of Physiology | 1982 |
| 7215668 | Glucose metabolism in the perfused heart of the foetal guinea pig. | Biochemical Society Transactions | 1981 |
| 6802587 | Metabolic events associated with the preparation of the fetus for independent life. | Ciba Foundation symposium | 1981 |